Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
10.34
+0.18 (1.77%)
At close: Dec 5, 2025, 4:00 PM EST
10.32
-0.02 (-0.19%)
After-hours: Dec 5, 2025, 5:01 PM EST
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $370.09 million as of December 5, 2025. Its market cap has decreased by -41.18% in one year.
Market Cap
370.09M
Enterprise Value
95.65M
1-Year Change
-41.18%
Ranking
Category
Stock Price
$10.34
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has increased from $251.01M to $370.09M, an increase of 47.44%. That is a compound annual growth rate of 9.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 370.09M | -39.54% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |